Adenovirus IgM CLIA Microparticles
- UID
- IMP/IVD/2019/000395_f7d6f8e6ed349d64a2b8a02e42e6f8f1_7fe3cd80cf9b85df79d743024a473723
- Device class
- Class B
- Brand name
- T4 CLIA Microparticles
- License holder
- Matrix Labs
- Approving authority
- CDSCO
- Product information
- This assay is based on a chemiluminescent microparticle immunoassay (T4 CLIA Microparticles) for the qualitative determination of Adenovirus IgM (T4 CLIA Microparticles) in human serum or plasma
Adenovirus IgM CLIA Microparticles is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000395_f7d6f8e6ed349d64a2b8a02e42e6f8f1_7fe3cd80cf9b85df79d743024a473723. This device is marketed under the brand name T4 CLIA Microparticles. The license holder is Matrix Labs, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.